[DOI] [PubMed] [Google Scholar] 17.Guo G.Y., Xu Q., Zhu C.Z., Yu J.L., Wang Q.J., Tang J., Huan Z.G., Shen H., Chang J., Zhang X.L
Upadacitinib Upadacitinib is a selective Janus kinase 1 inhibitor that is approved to treat ulcerative colitis
Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism
Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model
Ongoing research into neuroprotective agents aims to identify drugs or compounds that can mitigate the initial and secondary damage caused by TBI, targeting various pathways such as inflammation, excitotoxicity, and oxidative stress